Content area
Abstract
Epidemiological studies have revealed that radiation causes brain development abnormalities in atomic bomb survivors exposed in utero. Rat and mouse studies have also shown that prenatal exposure to low-linear energy transfer radiation induces developmental brain anomalies. Because the effects of prenatal irradiation on adult behavior patterns remain largely unknown, the present study investigated the effects of neutron exposure in utero on postnatal behavior patterns in mice. [C57BL/6J × C3H/He] hybrid (B6C3F1) mice were exposed to cyclotron-derived fast neutrons with peak energy of 10 MeV (0.02–0.2 Gy) or Cs-137 gamma-rays (0.2–1.5 Gy) on embryonic day 13.5. At 5.5–8 months of age, the neurobehavior of male offspring was examined by Rota-rod treadmill and locomotor activity. The accumulation of radio-labeled drug at muscarinic acetylcholine and serotonin receptors in mice from control and neutron-irradiated groups was determined by the tracer method. Locomotor activity during the dark period increased in the 0.02 Gy neutron-irradiated group. Furthermore, at 5.5 months of age, tracer binding in vivo to the muscarinic acetylcholine increased and to the serotonin receptors decreased in the 0.02 Gy neutron-irradiated group. In conclusion, the present study reveals that a certain "low-dose window" may exist for radiation-induced changes in neurobehavior and binding to neurotransmitter receptors, because there was correlation in neurobehavior and binding to neurotransmitter receptors in the 0.02 Gy neutron-irradiated group though there was not correlation in the neutron-irradiated groups more than 0.05 Gy.
Details
1 Department of Technical Support and Development, Fundamental Technology Center, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage, Chiba 263-8555, Japan
2 Department of Radiation Dosimetry, Research Center for Radiation Emergency Medicine, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage, Chiba 263-8555, Japan
3 Division of Analytical Chemistry, Department of Pharmaceutical Sciences, Nagasaki International University, 2825-7, Huis Ten Bosch Cho, Sasebo, Nagasaki 859-3298, Japan
4 Technical Advancement of Radiation Systems Section, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage, Chiba 263-8555, Japan
5 Office of International Affairs, Radiation Effects Association, Maruishi-Daini Bldg. 5F 1-9-16, Kajicho, Chiyoda-ku, Tokyo 101-0044, Japan
6 Department of Technical Support and Development, Fundamental Technology Center, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage, Chiba 263-8555, Japan; Office of International Affairs, Radiation Effects Association, Maruishi-Daini Bldg. 5F 1-9-16, Kajicho, Chiyoda-ku, Tokyo 101-0044, Japan
7 Experimental Radiobiology for Children's Health Research Group, Research Center for Radiation Protection, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage, Chiba 263-8555, Japan





